ICU Medical profit growth

Intravenous products: The Wall Street Journal report “ICU Medical Inc.’s (ICUI) second-quarter profit grew by 20% as demand for the company’s disposable medical products was stable despite the economic downturn. The company also raised its full-year earnings, revenue and margins targets, due to improvements in its existing businesses as well as its acquisition of Hospira Inc.’s (HSP) critical-care product line, which is expected to close in the third quarter. The $35 million acquisition is expected to add 1 cent to 2 cents a share in the second half of the year”.

Click here for the full story.

Other stories